Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457951

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457951

Surgical Procedures Market Size and Share Analysis by Type, Provider, Gender, Age Group - Global Industry Demand Forecast to 2030

PUBLISHED:
PAGES: 260 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The surgical procedures market was 110.0 million procedures in 2023, and it will increase to 137.5 million, advancing at a 3.3% compound annual growth rate, by 2030.

This is mainly because of the surging incidence of chronic disorders, particularly cancer and CVDs; coupled with the increasing elderly population.

Aging people are more vulnerable to chronic ailments like diabetes, cancer, cardiovascular diseases, and neurological disorders, which led to the growing need for surgical procedures. Likewise, the low levels of immunity make the elderly population more susceptible to infections, therefore resulting in an increase in the number of surgical procedures.

As per the World Health Organization, there were an estimated 20 million new cases of cancer and 9.7 million deaths in 2022.

The projected number of individuals who were alive within 5 years following a cancer diagnosis was 53.5 million.

Approximately 1 out of 5 people develop cancer in their lifetime, around 1 out of 12 women and 1 out of 9 men die from the ailment.

Moreover, as per a report, worldwide death counts because of CVD increase to 19.8 million in 2022 from 12.4 million in 1990 reflecting worldwide population growth as well as aging.

Furthermore, the technological improvements in the surgical process will further assist the growth of this industry in the years to come.

The high count of outpatient surgeries is offering significant growth opportunities to the industry. Outpatient surgeries do not mandate an overnight stay at the hospital. Currently, medical procedures are increasing at outpatient facilities due to technological improvements, counting the arrival of minimally invasive surgeries, and the accessibility of value-based care incentives.

North America is Leading Market

North America accounted for the largest share of the industry in 2023, of 50%. This is because of the existence of developed healthcare systems, along with the rising incidence of diseases like cardiac, orthopedic, and gastrointestinal disorders.

Moreover, the higher acceptance rate of cutting-edge devices as well as the change in the fondness toward outpatient surgeries are also aiding the regional industry growth.

APAC will advance at the fastest rate of approximately 3.5% in the coming years. This is because of the rising consciousness of chronic disorders, the arrival of developed surgical technologies, the increasing incidence of neurological disorders and traumatic injuries, and the flourishing healthcare and medical tourism sectors, in this region.

Segmentation Insights

The obstetric & gynecological category was the largest contributor to the industry in 2023, with approximately 30% share. This is ascribed to the increasing incidence of gynecological disorders, including polycystic ovary syndrome (PCOS), endometriosis, ovarian cysts, chronic pelvic pain, ovarian and uterine cancer, pelvic inflammatory disease, uterine fibroids, and adenomyosis.

Whereas, the ophthalmic category will advance at the fastest rate, of approximately 3.7%, in the years to come. This can be mainly because of the increasing occurrence of various ophthalmic disorders, such as glaucoma, diabetic retinopathy, and cataracts.

The hospital was the largest end user category in 2023, with approximately 45% share, and it will remain the largest throughout this decade. This is because of the high count of surgeries carried out in these healthcare settings globally; and the rising prevalence of various chronic ailments.

With the surging occurrence of chronic diseases across the globe, the need for surgical procedures will continue to increase in the years to come.

Product Code: 12799

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by provider
    • 1.4.3. Market size breakdown, by gender
    • 1.4.4. Market size breakdown, by age group
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Provider (2017-2030)
  • 6.5. Market Revenue, by Provider (2017-2030)
  • 6.6. Market Volume, by Gender (2017-2030)
  • 6.7. Market Revenue, by Gender (2017-2030)
  • 6.8. Market Volume, by Age Group (2017-2030)
  • 6.9. Market Revenue, by Age Group (2017-2030)
  • 6.10. Market Volume, by Region (2017-2030)
  • 6.11. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Provider (2017-2030)
  • 7.5. Market Revenue, by Provider (2017-2030)
  • 7.6. Market Volume, by Gender (2017-2030)
  • 7.7. Market Revenue, by Gender (2017-2030)
  • 7.8. Market Volume, by Age Group (2017-2030)
  • 7.9. Market Revenue, by Age Group (2017-2030)
  • 7.10. Market Volume, by Country (2017-2030)
  • 7.11. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Provider (2017-2030)
  • 8.5. Market Revenue, by Provider (2017-2030)
  • 8.6. Market Volume, by Gender (2017-2030)
  • 8.7. Market Revenue, by Gender (2017-2030)
  • 8.8. Market Volume, by Age Group (2017-2030)
  • 8.9. Market Revenue, by Age Group (2017-2030)
  • 8.10. Market Volume, by Country (2017-2030)
  • 8.11. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Provider (2017-2030)
  • 9.5. Market Revenue, by Provider (2017-2030)
  • 9.6. Market Volume, by Gender (2017-2030)
  • 9.7. Market Revenue, by Gender (2017-2030)
  • 9.8. Market Volume, by Age Group (2017-2030)
  • 9.9. Market Revenue, by Age Group (2017-2030)
  • 9.10. Market Volume, by Country (2017-2030)
  • 9.11. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Provider (2017-2030)
  • 10.5. Market Revenue, by Provider (2017-2030)
  • 10.6. Market Volume, by Gender (2017-2030)
  • 10.7. Market Revenue, by Gender (2017-2030)
  • 10.8. Market Volume, by Age Group (2017-2030)
  • 10.9. Market Revenue, by Age Group (2017-2030)
  • 10.10. Market Volume, by Country (2017-2030)
  • 10.11. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Provider (2017-2030)
  • 11.5. Market Revenue, by Provider (2017-2030)
  • 11.6. Market Volume, by Gender (2017-2030)
  • 11.7. Market Revenue, by Gender (2017-2030)
  • 11.8. Market Volume, by Age Group (2017-2030)
  • 11.9. Market Revenue, by Age Group (2017-2030)
  • 11.10. Market Volume, by Country (2017-2030)
  • 11.11. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Provider (2017-2030)
  • 12.5. Market Revenue, by Provider (2017-2030)
  • 12.6. Market Volume, by Gender (2017-2030)
  • 12.7. Market Revenue, by Gender (2017-2030)
  • 12.8. Market Volume, by Age Group (2017-2030)
  • 12.9. Market Revenue, by Age Group (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Provider (2017-2030)
  • 13.5. Market Revenue, by Provider (2017-2030)
  • 13.6. Market Volume, by Gender (2017-2030)
  • 13.7. Market Revenue, by Gender (2017-2030)
  • 13.8. Market Volume, by Age Group (2017-2030)
  • 13.9. Market Revenue, by Age Group (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Provider (2017-2030)
  • 14.5. Market Revenue, by Provider (2017-2030)
  • 14.6. Market Volume, by Gender (2017-2030)
  • 14.7. Market Revenue, by Gender (2017-2030)
  • 14.8. Market Volume, by Age Group (2017-2030)
  • 14.9. Market Revenue, by Age Group (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Provider (2017-2030)
  • 15.5. Market Revenue, by Provider (2017-2030)
  • 15.6. Market Volume, by Gender (2017-2030)
  • 15.7. Market Revenue, by Gender (2017-2030)
  • 15.8. Market Volume, by Age Group (2017-2030)
  • 15.9. Market Revenue, by Age Group (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Provider (2017-2030)
  • 16.5. Market Revenue, by Provider (2017-2030)
  • 16.6. Market Volume, by Gender (2017-2030)
  • 16.7. Market Revenue, by Gender (2017-2030)
  • 16.8. Market Volume, by Age Group (2017-2030)
  • 16.9. Market Revenue, by Age Group (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Provider (2017-2030)
  • 17.5. Market Revenue, by Provider (2017-2030)
  • 17.6. Market Volume, by Gender (2017-2030)
  • 17.7. Market Revenue, by Gender (2017-2030)
  • 17.8. Market Volume, by Age Group (2017-2030)
  • 17.9. Market Revenue, by Age Group (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Provider (2017-2030)
  • 18.5. Market Revenue, by Provider (2017-2030)
  • 18.6. Market Volume, by Gender (2017-2030)
  • 18.7. Market Revenue, by Gender (2017-2030)
  • 18.8. Market Volume, by Age Group (2017-2030)
  • 18.9. Market Revenue, by Age Group (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Provider (2017-2030)
  • 19.5. Market Revenue, by Provider (2017-2030)
  • 19.6. Market Volume, by Gender (2017-2030)
  • 19.7. Market Revenue, by Gender (2017-2030)
  • 19.8. Market Volume, by Age Group (2017-2030)
  • 19.9. Market Revenue, by Age Group (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Provider (2017-2030)
  • 20.5. Market Revenue, by Provider (2017-2030)
  • 20.6. Market Volume, by Gender (2017-2030)
  • 20.7. Market Revenue, by Gender (2017-2030)
  • 20.8. Market Volume, by Age Group (2017-2030)
  • 20.9. Market Revenue, by Age Group (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Provider (2017-2030)
  • 21.5. Market Revenue, by Provider (2017-2030)
  • 21.6. Market Volume, by Gender (2017-2030)
  • 21.7. Market Revenue, by Gender (2017-2030)
  • 21.8. Market Volume, by Age Group (2017-2030)
  • 21.9. Market Revenue, by Age Group (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Provider (2017-2030)
  • 22.5. Market Revenue, by Provider (2017-2030)
  • 22.6. Market Volume, by Gender (2017-2030)
  • 22.7. Market Revenue, by Gender (2017-2030)
  • 22.8. Market Volume, by Age Group (2017-2030)
  • 22.9. Market Revenue, by Age Group (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Provider (2017-2030)
  • 23.5. Market Revenue, by Provider (2017-2030)
  • 23.6. Market Volume, by Gender (2017-2030)
  • 23.7. Market Revenue, by Gender (2017-2030)
  • 23.8. Market Volume, by Age Group (2017-2030)
  • 23.9. Market Revenue, by Age Group (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Provider (2017-2030)
  • 24.5. Market Revenue, by Provider (2017-2030)
  • 24.6. Market Volume, by Gender (2017-2030)
  • 24.7. Market Revenue, by Gender (2017-2030)
  • 24.8. Market Volume, by Age Group (2017-2030)
  • 24.9. Market Revenue, by Age Group (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Provider (2017-2030)
  • 25.5. Market Revenue, by Provider (2017-2030)
  • 25.6. Market Volume, by Gender (2017-2030)
  • 25.7. Market Revenue, by Gender (2017-2030)
  • 25.8. Market Volume, by Age Group (2017-2030)
  • 25.9. Market Revenue, by Age Group (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Provider (2017-2030)
  • 26.5. Market Revenue, by Provider (2017-2030)
  • 26.6. Market Volume, by Gender (2017-2030)
  • 26.7. Market Revenue, by Gender (2017-2030)
  • 26.8. Market Volume, by Age Group (2017-2030)
  • 26.9. Market Revenue, by Age Group (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Provider (2017-2030)
  • 27.5. Market Revenue, by Provider (2017-2030)
  • 27.6. Market Volume, by Gender (2017-2030)
  • 27.7. Market Revenue, by Gender (2017-2030)
  • 27.8. Market Volume, by Age Group (2017-2030)
  • 27.9. Market Revenue, by Age Group (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Provider (2017-2030)
  • 28.5. Market Revenue, by Provider (2017-2030)
  • 28.6. Market Volume, by Gender (2017-2030)
  • 28.7. Market Revenue, by Gender (2017-2030)
  • 28.8. Market Volume, by Age Group (2017-2030)
  • 28.9. Market Revenue, by Age Group (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Stryker Corporation
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Becton, Dickinson and Company
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Olympus Corporation
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Zimmer Biomet
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Abbott Laboratories
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Boston Scientific Corporation
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Smith & Nephew
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Medtronic plc
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Cook Medical
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. CONMED Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!